StockData
AC Immune SA logo

AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30
$1.95−0.18 (-8.45%)

Close on Nov 20, 2026Market cap $198.40MP/E –Yield –

AC Immune gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for AC Immune

AC Immune has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More AC Immune figures

See a number that looks wrong?